thiazolyl blue has been researched along with Small Cell Lung Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igishi, T; Kodani, M; Matsumoto, S; Matsunami, K; Morita, M; Nakazaki, H; Shigeoka, Y; Shimizu, E; Sumikawa, T; Suyama, H; Takeda, K; Ueda, Y | 1 |
| Feng, YM; Guo, S; Li, N; Liu, LL; Min, J; Su, HC; Zhang, HL; Zhang, JP | 1 |
2 other study(ies) available for thiazolyl blue and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells.
Topics: Anthracyclines; Benzamides; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Imatinib Mesylate; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Small Cell Lung Carcinoma; Tetrazolium Salts; Thiazoles | 2010 |
Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer.
Topics: Apoptosis; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Colony-Forming Units Assay; Drug Combinations; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Integrin beta3; Laminin; Proteoglycans; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Small Cell Lung Carcinoma; Tetrazolium Salts; Thiazoles | 2012 |